StockStory.org on MSN
Gilead Sciences (GILD) Q2 earnings report preview: What to look for
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting earnings this Tuesday after market hours. Here’s ...
Wall Street expects sales to soar as several commercial launches approach.
Biotechnology firm Tiziana Life Sciences Ltd. TLSA on Friday revealed promising quantitative PET imaging results from the ...
Humigent, an AI-native company building the intelligence for life sciences, today announced the successful close of its Series A funding round, with participation from Z21 Ventures and First Rays ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
Caris Life Sciences proprietary WES/WTS/WGS technology and massive data advantage underpin its leadership in oncology ...
The U.S. life sciences industry is showing early signs of a sustained recovery, providing a potential catalyst for one of commercial real estate's most challenged sectors as renewed hiring and venture ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results